Tecsys Inc. (TSE:TCS – Get Free Report) Director David Brereton sold 600 shares of the firm’s stock in a transaction on Friday, August 15th. The stock was sold at an average price of C$36.93, for a total value of C$22,158.00. Following the completion of the transaction, the director directly owned 777,172 shares of the company’s stock, valued at approximately C$28,700,961.96. This trade represents a 0.08% decrease in their ownership of the stock.
Tecsys Price Performance
Shares of TCS stock opened at C$34.30 on Wednesday. The stock has a market cap of C$508.57 million, a P/E ratio of 114.33 and a beta of 1.04. Tecsys Inc. has a one year low of C$34.15 and a one year high of C$47.51. The stock has a fifty day moving average price of C$37.26 and a 200 day moving average price of C$39.83. The company has a debt-to-equity ratio of 2.64, a current ratio of 1.31 and a quick ratio of 1.40.
Tecsys Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 3rd. Shareholders of record on Friday, September 19th will be paid a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a yield of 1.0%. Tecsys’s dividend payout ratio is currently 111.67%.
Analyst Ratings Changes
Get Our Latest Stock Analysis on Tecsys
About Tecsys
Tecsys Inc is engaged in the development and sale of enterprise supply chain management software for distribution, warehousing, transportation logistics, point-of-use and order management. It also provides related consulting, education and support services. The company serves healthcare systems, services parts, third-party logistics, retail and general wholesale distribution industries.
Recommended Stories
- Five stocks we like better than Tecsys
- What is the Nasdaq? Complete Overview with History
- August’s Most Upgraded: 3 Stocks With +20 Price Target Increases
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- Business Services Stocks Investing
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
Receive News & Ratings for Tecsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tecsys and related companies with MarketBeat.com's FREE daily email newsletter.